The CRC patients were divided into two groups [CDO1 high TaqMeth V group (TaqMeth V > cut-off value); CDO1 low TaqMeth V group (TaqMeth V ≤ cut-off value)]. This evidence concerns the gene CDO1 and colorectal carcinoma.